Insider trading

Period: 120 months Stock: EW Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

253 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

253 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

253 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

253 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
253 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
253 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

253 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
26 Aug 2026
Chopra Daveen CVP, TMTT, Surgical & IHFM
Sold at will 2×
$2.89M 31,800 at 91.02
41.8%
Not planned
27 May 2026
BOBO DONALD E JR CVP,Strategy/Corp Development · indirect
Sold at will
$2.00M 23,145 at 86.42
19.0%
Not planned
12 May 2026
Zovighian Bernard J CEO · indirect
Sold on a plan 2×
$2.83M 36,351 at 77.93
75.1%
Sold half or more
9 Apr 2026
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan 2×
$1.04M 13,000 at 80.04
24.7%
Planned (10b5-1)
2 Apr 2026
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan 2×
$1.82M 22,680 at 80.16
51.6%
Sold half or more
11 Mar 2026
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan 2×
$1.10M 13,000 at 84.92
24.7%
Planned (10b5-1)
25 Feb 2026
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold at will
$2.01M 24,000 at 83.84
53.0%
Sold half or more
12 Feb 2026
Sold at will 2×
$1.72M 22,430 at 76.67
21.1%
Not planned
8 Dec 2025
Sold on a plan
$1.83M 21,487 at 85.21
20.2%
Planned (10b5-1)
10 Nov 2025
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan 2×
$1.08M 13,000 at 83.08
24.6%
Planned (10b5-1)
30 May 2025
Zovighian Bernard J CEO · indirect
Sold on a plan
$1.24M 16,099 at 77.21
62.7%
Sold half or more
5 Nov 2024
Wood Larry L Global President TAVR & Surg
Sold on a plan
$1.65M 25,000 at 65.91
11.2%
Planned (10b5-1)
2 May 2024
Sold on a plan 2×
$2.49M 29,350 at 84.77
86.7%
Sold half or more
1 May 2024
Lemercier Jean-Luc M CVP, EMEACLA and JAPAC
Sold on a plan 2×
$1.21M 14,400 at 84.21
7.6%
Planned (10b5-1)
8 Apr 2024
Lemercier Jean-Luc M CVP, EMEACLA
Sold on a plan 2×
$1.33M 14,400 at 92.32
7.6%
Planned (10b5-1)
8 Apr 2024
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan 2×
$1.15M 12,500 at 92.33
23.9%
Planned (10b5-1)
4 Apr 2024
Sold on a plan 4×
$2.71M 29,350 at 92.42
86.7%
Sold half or more
13 Mar 2024
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold on a plan
$1.32M 14,500 at 91.01
26.9%
Planned (10b5-1)
11 Mar 2024
Lemercier Jean-Luc M CVP, EMEACLA and JAPAC
Sold on a plan
$1.32M 14,400 at 91.68
7.7%
Planned (10b5-1)
4 Mar 2024
Sold on a plan 2×
$2.54M 29,350 at 86.67
86.7%
Sold half or more
15 Feb 2024
Szyman Catherine M. CVP, Critical Care
Sold at will
$2.31M 27,000 at 85.62
43.7%
Not planned
13 Feb 2024
Szyman Catherine M. CVP, Critical Care
Sold at will
$1.73M 20,000 at 86.46
36.5%
Not planned
12 Feb 2024
SELLERS ROBERT W.A. SVP, Corporate Controller
Sold at will
$1.06M 12,210 at 87.00
48.3%
Not planned
5 Feb 2024
Sold on a plan 4×
$2.57M 29,350 at 87.49
86.7%
Sold half or more
5 Jan 2024
Sold on a plan 2×
$2.14M 29,350 at 72.98
86.7%
Sold half or more
29 Dec 2023
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan
$1.11M 14,510 at 76.55
43.0%
Planned (10b5-1)
13 Dec 2023
Sold on a plan 4×
$2.19M 29,350 at 74.62
86.7%
Sold half or more
3 Nov 2023
Sold on a plan
$1.97M 29,350 at 67.18
86.7%
Sold half or more
2 Oct 2023
Sold on a plan
$2.02M 29,350 at 68.84
86.7%
Sold half or more
5 Sep 2023
Sold on a plan
$2.23M 29,350 at 75.86
86.7%
Sold half or more
7 Aug 2023
Sold on a plan 2×
$2.34M 29,350 at 79.87
35.1%
Planned (10b5-1)
5 Jul 2023
Sold on a plan 2×
$2.66M 29,350 at 90.78
35.1%
Planned (10b5-1)
1 Jun 2023
Sold on a plan 3×
$2.48M 29,350 at 84.46
25.4%
Planned (10b5-1)
10 May 2023
Ullem Scott B. CVP, Chief Financial Officer
Sold on a plan 2×
$7.15M 80,700 at 88.54
81.5%
Sold half or more
10 May 2023
MUSSALLEM MICHAEL A Chairman & CEO
Sold on a plan 2×
$1.76M 19,875 at 88.49
19.6%
Planned (10b5-1)
9 May 2023
Szyman Catherine M. CVP, Critical Care
Sold on a plan
$6.72M 75,600 at 88.94
72.6%
Sold half or more
28 Apr 2023
SELLERS ROBERT W.A. SVP, Corporate Controller
Sold at will
$1.07M 12,270 at 87.20
51.1%
Sold half or more
14 Apr 2023
MUSSALLEM MICHAEL A Chairman & CEO
Sold on a plan 2×
$1.67M 19,875 at 84.20
24.6%
Planned (10b5-1)
14 Mar 2023
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 2×
$1.54M 19,875 at 77.61
24.6%
14 Feb 2023
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 2×
$1.53M 19,875 at 77.00
11.2%
13 Jan 2023
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated
$1.55M 19,875 at 78.09
11.2%
14 Dec 2022
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 3×
$1.52M 19,875 at 76.39
11.2%
14 Nov 2022
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 3×
$1.47M 19,875 at 74.15
11.2%
14 Oct 2022
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 4×
$1.65M 19,875 at 82.84
11.2%
22 Sep 2022
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 3×
$1.67M 19,875 at 84.17
11.2%
15 Aug 2022
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 3×
$2.08M 19,875 at 104.74
11.2%
14 Jul 2022
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 3×
$1.91M 19,875 at 95.88
10.6%
14 Jun 2022
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 3×
$1.73M 19,875 at 86.96
11.2%
10 May 2022
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 4×
$3.09M 32,550 at 94.82
17.1%
9 May 2022
Lemercier Jean-Luc M CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
$1.14M 11,560 at 98.24
6.6%
Showing 1–50 of 253. Page 1 of 6 Older →